Services
FUNDRAISING
M&A
LICENSING
STRATEGIC CONSULTING
Transactions
Team
News
Contact
Domain Therapeutics
Domain Therapeutics receives a single digit multimillion development milestone payment from Merck for M1069 clinical development in immuno-oncology
Show more
Domain Therapeutics raises $42m Series A financing
Show more
Ono Enters into Collaboration Agreement with Domain Therapeutics and Université de Montréal for GPCR-Targeted Drug Discovery
Show more
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
Show more
CONDOR project for precision medicine and sarcoma immunotherapy awarded close to €10m in the fifth call for hospital-university research in health (RHU) projects
Show more
Domain Therapeutics launches Phase 1-enabling studies on proprietary EP4 receptor antagonist program in cancer immunotherapy
Show more